WC
The startup operates a proprietary single-cell sequencing platform that combines wet lab techniques with machine learning to deliver precise long-read sequencing of RNA across large cell populations. This technology enables the identification and isolation of rare cell types and the discovery of previously undruggable therapeutic targets, facilitating the development of more effective therapies in targeted immunotherapies and genetic medicine.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a proprietary single-cell sequencing platform that combines wet lab techniques with machine learning to deliver precise long-read sequencing of RNA across large cell populations. This technology enables the identification and isolation of rare cell types and the discovery of previously undruggable therapeutic targets, facilitating the development of more effective therapies in targeted immunotherapies and genetic medicine.